Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lineage Cell Therapeutics, Inc. Common Stock
(NY:
LCTX
)
1.850
+0.010 (+0.54%)
Official Closing Price
Updated: 8:00 PM EST, Mar 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Lineage Cell Therapeutics, Inc. Common Stock
< Previous
1
2
3
4
Next >
Lineage Cell Therapeutics (LCTX) Reports Q4 Revenue Beat and Narrowed Loss
↗
March 05, 2026
Via
Chartmill
Lineage Cell Therapeutics Inc (NYSEARCA:LCTX) Reports Q3 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss
↗
November 06, 2025
Lineage Cell Therapeutics reports Q3 2025 results with a revenue beat but a wider net loss. The company advances its cell therapy pipeline and has cash into 2027.
Via
Chartmill
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 22, 2025
Via
Benzinga
5 Analysts Assess Lineage Cell Therapeutics: What You Need To Know
↗
August 27, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
August 15, 2025
Via
Benzinga
A Peek at Lineage Cell Therapeutics's Future Earnings
↗
August 11, 2025
Via
Benzinga
Beyond The Numbers: 7 Analysts Discuss Lineage Cell Therapeutics Stock
↗
March 11, 2025
Via
Benzinga
Forecasting The Future: 6 Analyst Projections For Lineage Cell Therapeutics
↗
January 31, 2025
Via
Benzinga
Lineage Cell Revenue Doubles in Q2
↗
August 12, 2025
Via
The Motley Fool
Lineage Cell Therapeutics Inc. (NYSEARCA:LCTX) Reports Q2 2025 Revenue Beat but Wider Loss
↗
August 12, 2025
Lineage Cell Therapeutics Q2 2025: Revenue beats estimates at $2.77M (+84.6%), but net loss widens to -$0.13. Stock dips 4.95% amid clinical progress and cash runway into 2027.
Via
Chartmill
Two Biotech Stocks Poised For Big Moves On Monday
↗
June 23, 2025
Via
Benzinga
Examining the Future: Lineage Cell Therapeutics's Earnings Outlook
↗
May 12, 2025
Via
Benzinga
Which stocks are moving after the closing bell on Wednesday?
↗
April 16, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
The Analyst Verdict: Lineage Cell Therapeutics In The Eyes Of 4 Experts
↗
January 03, 2025
Via
Benzinga
Lineage Cell Therapeutics's Earnings Outlook
↗
November 13, 2024
Via
Benzinga
Lineage Cell Therapeutics: Q4 Earnings Insights
↗
March 07, 2024
Via
Benzinga
Earnings Scheduled For August 12, 2025
↗
August 12, 2025
Via
Benzinga
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
April 15, 2025
Via
Benzinga
Earnings Scheduled For March 10, 2025
↗
March 10, 2025
Via
Benzinga
A Preview Of Lineage Cell Therapeutics's Earnings
↗
March 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 20, 2024
Via
Benzinga
LCTX Stock Earnings: Lineage Cell Therapeutics Beats EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
LCTX stock results show that Lineage Cell Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
LCTX Stock Earnings: Lineage Cell Therapeutics Meets EPS, Beats Revenue for Q1 2024
↗
May 09, 2024
LCTX stock results show that Lineage Cell Therapeutics met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
LCTX Stock Earnings: Lineage Cell Therapeutics Beats EPS, Beats Revenue for Q4 2023
↗
March 07, 2024
LCTX stock results show that Lineage Cell Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 14, 2024
Via
Benzinga
Earnings Scheduled For November 14, 2024
↗
November 14, 2024
Via
Benzinga
Earnings Scheduled For March 7, 2024
↗
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
